Embryonic stem cells: From bench to bedside

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 3, 2007, Pages 337-339

  Puceat M ^a   Ballis, A ^a  

^a UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MICRORNA;

ANIMAL CELL; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL REGENERATION; CELL THERAPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; ECONOMIC ASPECT; EMBRYO; EMBRYONIC STEM CELL; EPITOPE MAPPING; GENE AMPLIFICATION; GENETIC STABILITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SAFETY; SHORT SURVEY; SKIN FIBROBLAST; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION;

BLOOD BANKS; EMBRYONIC STEM CELLS; GENETICS; HUMANS; MICRORNAS; STEM CELL TRANSPLANTATION;

EID: 34547918308     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100298     Document Type: Short Survey

References (13)

1. Ludwig, T.E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187 (2006).
2. Amit, M. et al. No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells 23, 761-771 (2005).
3. Nasonkin, I.O. & Koliatsos, V.E. Nonhuman sialic acid Neu5Gc is very low in human embryonic stem cell-derived neural precursors differentiated with B27/N2 and noggin: implications for transplantation. Exp. Neurol. 201, 525-529 (2006).
4. Cabrera, C.M. et al. The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level. Cell Biol. Int. 20, 20 (2007).
5. Li, L. et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22, 448-456 (2004).
6. Taylor, C.J. et al. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366, 2019-2025 (2005).
7. Priddle, H., Jones, D.R., Burridge, P.W. & Patient, R. Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies. Stem Cells 24, 815-824 (2006).
8. Roy, N.S. et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12, 1259-1268 (2006).
9. Tomescot, A. et al. Differentiation in vivo of cardiac committed human embryonic stem cells in post-myocardial infarcted rats. Stem. Cells (in press, 2007) early publication May 31.
10. Baker, D.E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215 (2007).
11. Mitalipov, S., Clepper, L., Sritanaudomchai, H., Fujimoto, A. & Wolf, D. Methylation status of imprinting centers for H19/IGF2 and SNURF/SNRPN in primate embryonic stem cells. Stem Cells 25, 581-588 (2007).
12. Allegrucci, C. et al. Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Hum. Mol. Genet. 16, 1253-1268 (2007).
13. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R. & Jacks, T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39, 673-677 (2007).